
BusinessLead story
Kevin Weil's Warp Sciences launches with $215M to speed up AI drug development
The former OpenAI product chief's startup came out of stealth at an $865M post-money valuation in a round led by Lightspeed.
Jaeden SchaferEditor in Chief3 min read